They copy the action of a natural hormone in your body called GLP-1 (glucagon-like peptide-1), which is released after you eat
Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study
The GLP-1 patch format represents another alternative delivery route worth discussing with your provider
While we anticipate retatrutide being a strong option for many people seeking weight loss, it may be particularly useful for anyone who falls into one or more of these categories: Didnt respond to earlier GLP-1 drugs like Wegovy, Ozempic, Rybelsus, Liraglutide, Zepbound, Mounjaro, etc Plateaued with other GLP-1s but still havent met your target weight Have a large body percentage of weight to lose (20% or more) Retatrutide is currently undergoing clinical trials necessary for it to obtain FDA approval (which is anticipated by summer) , so it's not yet available to be prescribed
This highlights the emphasis on tailored treatment responses and ongoing assessment in patient care
Tailored advice can prevent complications and maximize treatment benefits